What to Know About the USPTO’s Duty of Candor Guidance Regarding FDA Submissions
Fish & Richardson Trademark & Copyright Thoughts
SEPTEMBER 16, 2022
The Notice extends these duties broadly to “each individual associated with the filing and prosecution of a patent application” and “each individual associated with the patent owner in a reexamination proceeding.” If, upon review, “any reviewed document is material to the patentability of a pending matter before the Office.
76 
Let's personalize your content